Valtrex Tablet, Film Coated
Product Images NDC 70518-2039

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Valtrex (NDC 70518-2039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Valtrex is a prescription drug with active ingredient Valacyclovir HCI. It is manufactured by GlaxoSmithKline in Research Triangle Park, NC, and the NDC number is 70518-2039-00. The package insert should be consulted for directions of use. The medication should be stored at a temperature between 20-26°C (63-77°F), with permissible excursions to 15-30°C (59-86°F) [See USP]. It is important to keep this medication out of reach of children. The drug is repackaged by RemedyRepack Inc., Indiana, PA.*
FDA Label Image

Valacyclovir Hydrochloride Chemical Structure (Valtrex Spl Graphic 01)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.